Page last updated: 2024-10-29

iohexol and Hepatitis B, Chronic

iohexol has been researched along with Hepatitis B, Chronic in 3 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

Research Excerpts

ExcerptRelevanceReference
"Plasmas from chronic hepatitis B (CHB) patients, HBeAg positive or negative, genotype D or E, were fractionated on velocity and equilibrium gradients with or without detergent treatment."1.72Characterization of hepatitis B viral forms from patient plasma using velocity gradient: Evidence for an excess of capsids in fractions enriched in Dane particles. ( Besombes, J; Bomo, J; Genet, V; Gripon, P; Laperche, S; Pronier, C; Thibault, V, 2022)
"Common enhancement pattern of intrahepatic cholangiocarcinoma (ICC) on computed tomography (CT) is that of hypovascular enhancement; however, in some cases, tumor shows identical enhancement in the arterial phase to that in hepatocellular carcinoma."1.35Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma. ( Abo, T; Fukuoka, H; Hidaka, S; Murakami, G; Nagayasu, T; Nanashima, A; Oikawa, M; Sakamoto, I; Sawai, T; Sumida, Y; Takeshita, H, 2008)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Pronier, C3
Bomo, J3
Besombes, J3
Genet, V3
Laperche, S3
Gripon, P3
Thibault, V3
Li, R1
Cai, P1
Ma, KS1
Ding, SY1
Guo, DY1
Yan, XC1
Nanashima, A1
Sumida, Y1
Abo, T1
Oikawa, M1
Murakami, G1
Takeshita, H1
Fukuoka, H1
Hidaka, S1
Nagayasu, T1
Sakamoto, I1
Sawai, T1

Other Studies

3 other studies available for iohexol and Hepatitis B, Chronic

ArticleYear
Characterization of hepatitis B viral forms from patient plasma using velocity gradient: Evidence for an excess of capsids in fractions enriched in Dane particles.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Capsid; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B v

2022
Characterization of hepatitis B viral forms from patient plasma using velocity gradient: Evidence for an excess of capsids in fractions enriched in Dane particles.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Capsid; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B v

2022
Characterization of hepatitis B viral forms from patient plasma using velocity gradient: Evidence for an excess of capsids in fractions enriched in Dane particles.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Capsid; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B v

2022
Characterization of hepatitis B viral forms from patient plasma using velocity gradient: Evidence for an excess of capsids in fractions enriched in Dane particles.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Capsid; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B v

2022
Characterization of hepatitis B viral forms from patient plasma using velocity gradient: Evidence for an excess of capsids in fractions enriched in Dane particles.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Capsid; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B v

2022
Characterization of hepatitis B viral forms from patient plasma using velocity gradient: Evidence for an excess of capsids in fractions enriched in Dane particles.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Capsid; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B v

2022
Characterization of hepatitis B viral forms from patient plasma using velocity gradient: Evidence for an excess of capsids in fractions enriched in Dane particles.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Capsid; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B v

2022
Characterization of hepatitis B viral forms from patient plasma using velocity gradient: Evidence for an excess of capsids in fractions enriched in Dane particles.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Capsid; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B v

2022
Characterization of hepatitis B viral forms from patient plasma using velocity gradient: Evidence for an excess of capsids in fractions enriched in Dane particles.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Capsid; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B v

2022
Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma.
    Scientific reports, 2016, 05-26, Volume: 6

    Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagn

2016
Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma.
    Journal of surgical oncology, 2008, Dec-01, Volume: 98, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; C

2008